Author

Francesca Pica

Universit

Biography

Francesca Pica is from Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy and has research interest in Immunology of Infectious Diseases, Immunity, Cell Culture, Immunology
Title
Cited by
Year
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication
SJ Griffiths, M Koegl, C Boutell, HL Zenner, CM Crump, F Pica, ...PLoS Pathogens 9 (8), e1003514, 2013201
104
2013
Thymosin α1 and cancer: Action on immune effector and tumor target cells
E Garaci, F Pica, A Serafino, E Balestrieri, C Matteucci, G Moroni, ...Annals of the New York Academy of Sciences 1269 (1), 26-33, 2012201
92
2012
Clinical and psychosocial correlates of post‐herpetic neuralgia
A Volpi, A Gatti, F Pica, S Bellino, LT Marsella, AF SabatoJournal of medical virology 80 (9), 1646-1652, 2008200
82
2008
Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives
R Gaziano, G Moroni, C Buè, MT Miele, P Sinibaldi-Vallebona, F PicaWorld Journal of Gastrointestinal Oncology 8 (1), 30, 2016201
77
2016
HERVs expression in autism spectrum disorders
E Balestrieri, C Arpino, C Matteucci, R Sorrentino, F Pica, R Alessandrelli, ...PloS one 7 (11), e48831, 2012201
61
2012
Transcriptional activity of human endogenous retroviruses in human peripheral blood mononuclear cells
E Balestrieri, F Pica, C Matteucci, R Zenobi, R Sorrentino, ...BioMed research international 2015, 2015201
52
2015
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture
I Carunchio, L Curcio, M Pieri, F Pica, S Caioli, MT Viscomi, M Molinari, ...Experimental neurology 226 (1), 218-230, 2010201
49
2010
Thymosin α1 as a stimulatory agent of innate cell‐mediated immune response
A Serafino, P Pierimarchi, F Pica, F Andreola, R Gaziano, N Moroni, ...Annals of the New York Academy of Sciences 1270 (1), 13-20, 2012201
46
2012
Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer
F Pica, E Balestrieri, A Serafino, R Sorrentino, R Gaziano, G Moroni, ...Anti-Cancer Drugs 23 (1), 32-42, 2012201
45
2012
Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages
A Serafino, F Pica, F Andreola, R Gaziano, N Moroni, G Moroni, ...Journal of Innate Immunity 6 (1), 72-88, 2014201
36
2014
Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies
E Zorzoli, F Pica, G Masetti, E Franco, A Volpi, G GabuttiAging clinical and experimental research 30, 693-702, 2018201
35
2018
No evidence of family history as a risk factor for herpes zoster in patients with post‐herpetic neuralgia
A Gatti, F Pica, MTY Boccia, F De Antoni, AF Sabato, A VolpiJournal of medical virology 82 (6), 1007-1011, 2010201
31
2010
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
E Giacomini, F Rizzo, MP Etna, M Cruciani, R Mechelli, MC Buscarinu, ...Multiple Sclerosis Journal 24 (2), 127-139, 2018201
29
2018
Historical review on thymosin α1 in oncology: preclinical and clinical experiences
E Garaci, F Pica, C Matteucci, R Gaziano, C D’Agostini, MT Miele, ...Expert Opinion on Biological Therapy 15 (sup1), 31-39, 2015201
29
2015
High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders
C Cipriani, L Ricceri, C Matteucci, A De Felice, AM Tartaglione, ...Scientific reports 8 (1), 629, 2018201
28
2018
Interferon-λ in immunocompetent individuals with a history of recurrent herpes labialis
F Pica, A Volpi, R Gaziano, E GaraciAntiviral therapy 15 (5), 737-743, 2010201
24
2010
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90
R Gaziano, E Campione, F Iacovelli, D Marino, F Pica, P Di Francesco, ...Drug design, development and therapy, 2185-2193, 2018201
23
2018
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases
F Pica, MS Chimenti, R Gaziano, C Buè, IA Casalinuovo, P Triggianese, ...Clinical & Experimental Immunology 186 (1), 39-45, 161
20
2016
Thymosin α1 interacts with exposed phosphatidylserine in membrane models and in cells and uses serum albumin as a carrier
W Mandaliti, R Nepravishta, P Sinibaldi Vallebona, F Pica, E Garaci, ...Biochemistry 55 (10), 1462-1472, 2016201
19
2016
Serum thymosin alpha 1 levels in normal and pathological conditions
F Pica, R Gaziano, IA Casalinuovo, G Moroni, C Buè, D Limongi, ...Expert Opinion on Biological Therapy 18 (sup1), 13-21, 2018201
19
2018

Referred From: https://scholar.google.com/citations?user=b9p0OfsAAAAJ&hl=it

Cited by
Citations 2379
h-index 29
i10-index 56
Open Access Journals